New malaria prevention drug trial launches in africa
NCT ID NCT06408857
First seen May 13, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study tests a new drug called MAM01 to see if it can safely prevent malaria for at least 4 months. It involves 125 healthy adults and children in Africa where malaria is common. The trial will find the best dose and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IDRC-Infectious Disease Research Collaboration, IDRC Tororo Hospital Station Road
Tororo, 749, Uganda
-
JCRC-Joint Clinical Research Centre
Kampala, 10005, Uganda
Conditions
Explore the condition pages connected to this study.